Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Deals, December 18, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is AstraZeneca plc’s acquisition of Alexion Pharmaceuticals, Inc. for $39 billion. Alexion is a global biopharmaceutical company that has pioneered complement inhibition for a broad spectrum of immune-mediated rare diseases caused by uncontrolled activation of the complement system, a vital part of the immune system. Alexion’s expertise... Read More »
What a Year It Was for Hospital M&A
The U.S. hospital system has had a stress-filled year, to say the least. By mid-December 2020, the nation’s death toll from the coronavirus topped 300,000 and daily hospitalizations closed in on 11,000. Front-line healthcare workers began receiving the Pfizer-BioNtech vaccine and Dr. Anthony Fauci, the nation’s top infectious disease expert, told MSNBC in an interview that the timeline for a return to normalcy stretched well into 2021. Not surprisingly, the hospital merger and acquisition landscape shifted, but it didn’t buckle. Overall, deals for hospitals are down 26% through mid-December (73 vs. 99 in 2019). For U.S. hospitals, deal volume dropped 16% (66 U.S. deals... Read More »
PointClickCare Technologies Adds Collective Medical
PointClickCare Technologies Inc. announced last week it is acquiring Collective Medical in an effort to more than double its platform size. PointClickCare Technologies is a software platform supporting a network of more than 21,000 skilled nursing facilities, senior living communities and home health agencies. It is backed by JMI Equity and Dragoneer Investment Group. Collective Medical is a leading real-time care notification, activation, and collaboration platform. The company’s platform collects data from electronic health records (EHRs) and health information exchanges to help providers make informed decisions. Sources cited in Business Insider value the merger at approximately... Read More »
AstraZeneca Buys Alexion In $39 Billion-Mega Deal
The global pharmaceutical giant AstraZeneca plc (NYSE: AZN) is back with its fifth deal of the year, and its biggest one at that. AstraZeneca is buying Boston, Massachusetts-based Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) for $39 billion. Alexion is a global biopharmaceutical company that has pioneered complement inhibition for a broad spectrum of immune-mediated rare diseases caused by uncontrolled activation of the complement system, a vital part of the immune system. According to the terms of the agreement, Alexion shareholders will receive $60 cash and 2.1243 AstraZeneca American Depositary Shares (ADS) per share (each ADS equals 1/2 AZN share). Based on AstraZeneca’s... Read More »
Tenet Healthcare Acquires 45 ASCs For More Than $1 Billion
Tenet Healthcare Corporation (NYSE: THC) has significantly expanded its ambulatory surgery platform with a new acquisition. The Texas-based health system has purchased a portfolio of 45 ambulatory surgery centers (ASCs) located in Arizona, Florida, Indiana, Louisiana, Maryland, New Hampshire, Ohio, Texas and Wisconsin from SurgCenter Development (SCD), which partners with local surgeons to create physician-owned and physician-operated ASCs. Tenet Healthcare will buy the majority interests by fully acquiring SCD’s interests, and partially acquiring interests from physician partners, for $1.1 billion in cash and the assumption of approximately $18 million of center-level debt. The ASCs will... Read More »
Health Care M&A Deals, December 11, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Boehringer Ingelheim’s acquisition of NBE-Therapeutics for $1.429 billion from PPF Group. NBE-Therapeutics is a clinical-stage biotechnology company focused on antibody-drug conjugate (ADC) therapies for the treatment of solid tumors. NBE-Therapeutics’ lead compound NBE-002 is currently in Phase 1 clinical studies for triple negative breast... Read More »
Health Care M&A Deals, December 4, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is AdaptHealth Corp.’s (NASDAQ: AHCO) acquisition of AeroCare Holdings, Inc. for $2 billion from SkyKnight Capital. AeroCare Holdings is a home health distribution platform, providing service and equipment to patients with chronic respiratory conditions. Its network of over 260 locations across the U.S. provides service to more than 500,000... Read More »
Boston Scientific Divests BTG Specialty Pharmaceuticals Business
In November 2018, Boston Scientific Corporation (NYSE: BSX) purchased BTG plc for $4.8 billion, according to search results in our Healthcare Deal Database. BTG develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases. However, the company also had an acute care pharmaceutical division, which based on recent deal activity, it seemed the medical device giant wasn’t too interested in holding onto the non-medical device portions of BTG. In the fourth quarter of 2019, Boston Scientific sold the pharmaceutical licensing royalties unit of BTG, and last week, the company announced the second divestment. Boston Scientific is selling... Read More »
AdaptHealth Corp. acquires AeroCare Holdings
In the third deal of the year for AdaptHealth Corp. (NASDAQ: AHCO), the company has announced it has acquired AeroCare Holdings, Inc. from private equity firm SkyKnight Capital. AeroCare is a home health distribution platform, providing service and equipment to patients with chronic respiratory conditions. Its network of over 260 locations across the U.S. provides service to more than 500,000 patients and partners with more than 45,000 physicians annually. The deal is valued at $2 billion, consisting of a $1.1 billion cash payment and 31 million shares of AdaptHealth common stock. SkyKnight Capital only just bought AeroCare Holdings in October 2019 for an undisclosed sum, according to... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
